Skip Navigation
Office of the Secretary of Transportation
Home Citizen Services Business Services Government Services Contact Us

 

Home > Office of the Secretary of Transportation > Office of Drug & Alcohol Policy & Compliance

Office of Drug & Alcohol Policy & Compliance










 

Highlights of DOT’S Revised 49 CFR Part 40
Workplace Drug and Alcohol Testing Procedures

The Department of Transportation has issued its revised rule governing drug and alcohol testing procedures (49 CFR Part 40).

The rule was published in the Federal Register on Tuesday, December 19, 2000, and is on the DOT web site at http://www.dot.gov/ost/dapc/NEW_DOCS/part40.html?proc.  Most provisions of the rule go into effect August 1, 2001, but some provisions – additional safeguards for employees in validity testing and a service agent accountability mechanism – went into effect on January 18, 2001. Additionally, DOT published in the Federal Register a technical amendment to Part 40 on August 9, 2001 to clarify certain provisions of the rule and address omissions and minor problems.

The following are some of the key provisions of the new rule:

Specimen Validity Testing (SVT).  The requirement for medical review officer (MRO) review of substitution and adulteration test results and the employee option to request split specimen testing for these results went into effect January 18, 2001.  Specimen validity testing currently is voluntary (for emplyers and laboratories) but will become mandatory when the Department of Health and Human Services (HHS) Mandatory Guidelines are issued in the near future.

Stand-Down.  Temporarily removing employees from safety-sensitive duties after a confirmed positive, adulterated, or substituted laboratory test result, but before the MRO has verified the result (stand-down) is generally prohibited.  However, employers can request a waiver permitting stand-down.  Waiver requests must include a written stand-down policy providing, among other things, for confidentiality of information about the test, paying workers during the stand-down period, and expunging records of the confirmed test result if the test is verified negative or cancelled.  The request for a waiver must be directed to the individual operating administrations and must be obtained prior to initiating a stand-down policy.

Public Interest Exclusions (PIE).  The final rule includes a public interest exclusion mechanism designed to protect the public from the effects of serious noncompliance by service agents.  A service agent who engaged in serious misconduct could be excluded from participating in DOT-required drug and alcohol testing for a period of time.  Employers will have the ability to determine which service agents have been excluded through announcements in the Federal Register and by looking at the DOT web site.  In response to comments, the final rule’s PIE provision lists examples of noncompliance that could subject a service agent to a PIE proceeding and provides extensive administrative due process to ensure fairness.  The PIE provision went into effect January 18, 2001.

Training.  A well-trained work force is vital to an accurate and fair drug- and alcohol-testing program.  For this reason, Part 40 includes enhanced training requirements for collectors, breath alcohol technicians (BATs), screening test technicians (STTs), medical review officers (MROs), and substance abuse professionals (SAPs).  This includes initial ("qualification") training, refresher training every five years (for collectors, BATs, and STTs), continuing education (for MROs and SAPs), and "error correction training" (for collectors, STTs, and BATs) following a mistake that causes a test to be cancelled.

Collection Process.  All collections – including those under the Research and Special Programs Administration (pipeline industry) and the U.S. Coast Guard – are now conducted as split specimen collections.  A collection under direct observation will be required following a situation in which a test is cancelled because the split specimen was unavailable, but not following a negative dilute test result.  Otherwise, direct observation testing is the same as under the previous rule.  A body temperature is no longer required when the first specimen’s temperature is out of range.  An employee’s decision not to drink fluids in a "shy bladder" situation will not be regarded as a refusal to test.  Collectors will not require employees to remove their boots, but are required to ask employees to display the contents of their pockets.  A new, shorter version of the Federal Drug Testing Custody and Control Form was developed for use starting August 1, 2001, together with a standard urine collection kit.

Laboratory Process.  All laboratories will be required to initiate validity testing on all specimens starting August 1, 2001.  However, this requirement will not become mandatory until HHS publishes their Mandatory Guidelines. The new rule also permits transmission of laboratory results to the MRO electronically eliminating the need for transmission of paper documents for negative results.  The number of blind specimens that an employer has to submit to laboratories has been reduced substantially and laboratory statistical reports have been reduced from four to two per year.

Medical Review Officer (MRO).  The prohibition against MROs having any relationship with a laboratory that may create a conflict of interest is restated in the new regulation.  MROs are required to personally conduct a verification interview with the employee not only for drug positive results, but also when the specimen is reported as adulterated or substituted.  For opiate verification, if either morphine or codeine is reported at or above 15,000 ng/mL, the burden for explaining its presence shifts to the employee.  In specific cases when a result is invalid or rejected for testing, the MRO may require a recollection under direct observation.  The MRO is required to release certain medical information to third parties if that information indicates a safety issue related to the employee’s continued performance of safety-sensitive functions.  The rule also indicates specific situations that the MRO is prohibited from doing during the verification process.

Alcohol Testing.  There are few procedural changes in the alcohol testing requirements.  A new Breath Testing Form with minor changes was developed and its use was required as of August 1, 2001.  The rule spells out procedures to correct problems in the testing process, identifies fatal flaws, describes what constitutes a refusal, and addresses "shy lung" procedures.

Substance Abuse Professional (SAP) and the Return-to-Duty Process.  All positive tests and refusals to test now have a consequence.  SAPs must require education and/or treatment in all such cases.  The return-to-duty process is mandatory following any violation of the rules, including a positive on a pre-employment test.  The number of follow-up tests remains the same as under the previous rule:  a minimum of 6 tests in the first 12 months following return to duty.  Employers may, but are not required, monitor aftercare for employees who have returned to work following a violation.  Return-to-duty process and follow-up testing requirements continue to apply even if workers change jobs or have a break in service.

Role of Consortia/Third-Party Administrators (C/TPAs).  With some exceptions (e.g., transmission of medical information from MROs to employers, transmission of SAP reports to employers), employers may choose to have drug test results and other information transmitted to them via a C/TPA or directly from the MRO or other person who generates the information.  As service agents, C/TPAs are not "employers" for purposes of the rule and cannot play the "designated employer representative" (DER) role for employers.  C/TPAs cannot receive test results from laboratories.

Other Issues.  Employers will be required to obtain, from an applicant's previous employers over the past two years, drug and alcohol testing information.  "Blanket releases" for testing informatino continue to be prohibited. The new rule takes steps to authorize greater use of electronic means of transmitting and storing data and also addresses specific requirements for releasing information to employees at their request and clarifies when such information may be released to other third parties.

Conforming Rulemakings.  All six DOT agencies involved in the drug- and alcohol-testing program issued proposed modifications to their regulations in the Federal Register in late Summer 2001, to ensure that their regulations are consistent with the new Part 40.

 

last updated on: 04/10/06

 

Home | DOT Agencies | About DOT | News | FAQs | Safety | Dockets | Careers | FOIA
The White House - President George W. Bush USA Freedom Corps First Gov - your first click to the U.S. Government Regulations.gov Department of Transportation Agencies